Clinical Trial Update: Safety and Efficacy of Sustained Erythropoietin Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and efficacy of sustained erythropoietin therapy in anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Medgenics Medical Israel Ltd. | Conditions: Anemia | Phase 1, Phase 2 | Status: COMPLETED